Skip to main content

The discoveries, concepts and promise
of curing sickle cell disease

More than a half-century ago, entertainer Danny Thomas envisioned a hospital that would treat children regardless of race, color, creed or their family's ability to pay. A facility where research would shine light into the darkness.




St. Jude presents Lemuel Diggs, MD, with a $10,000 grant for his work on sickle cell disease. Diggs subsequently publishes the first comprehensive study of sickle cell disease and its impact on the African-American population.


February 4, 1962

The hospital opens in Memphis, Tennessee, before a crowd of 9,000 people.

St. Jude opens during a turbulent era in American history. The star-shaped building designed by renowned African-American architect Paul Revere Williams immediately becomes the region's first fully integrated hospital. The integration of St. Jude also extends to the Memphis hotel industry. In order to house St. Jude families, a facility must agree to offer housing to anyone, regardless of race.

Dr. Rudolph


African-American physician Rudolph Jackson, MD, helps establish the sickle cell program at St. Jude.



St. Jude launches the first major effort to understand the lifelong progression of sickle cell disease.


Former St. Jude patient Kimberlin Wilson-George


A St. Jude cancer patient with both sickle cell disease and cancer undergoes a bone marrow transplant to target her cancer.

However, the procedure also cures her sickle cell disease and she becomes the first person in the world cured of sickle cell disease through a bone marrow transplant.  That discovery occurs because St. Jude is committed to studying multiple pediatric diseases.




The St. Jude sickle cell program is named one of 10 Comprehensive Sickle Cell Centers by the National Heart, Lung, and Blood Institute.



Sickle cell pioneer Winfred Wang, MD, of St. Jude Hematology leads nationwide research to advance the use of hydroxyurea in children — currently the only approved drug for the treatment of sickle cell disease.



“We must do what others cannot do.”

St. Jude President and CEO James Downing, MD, unveils a bold plan for saving the lives of children around the globe — extending clinical research for sickle cell beyond symptom management to cures. 



A Sickle Cell Disease Transition Clinic is created to help 18-year-olds make the leap from St. Jude to adult-care facilities of their choice.


Links of Memphis donate to St. Jude

St. Jude is the first health care organization to receive the Legacy Grant from The Links Foundation Inc., to support the advancement of sickle cell disease research.


Help the legacy continue so families can focus on what matters most

Donate Now